Main Logo
+17162654855
[email protected]

Innovation Trends in Europe Animal Vaccines Market: Market Outlook 2026-2034

Europe Animal Vaccines Market by Animal Vaccine Type (Livestock Vaccines, Companion Animal Vaccines), by Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Technologies), by Germany, by United Kingdom, by France, by Spain, by Italy, by Rest of Europe Forecast 2026-2034

Base Year: 2025
234 Pages
Main Logo

Innovation Trends in Europe Animal Vaccines Market: Market Outlook 2026-2034

About Precision Market View

Precision Market View offers precise market research, industry intelligence, and data analysis for healthcare, manufacturing, technology, and energy. Our reports provide the clarity you need to make informed decisions and drive growth.

Our team combines primary research, advanced analytics, and industry expertise to deliver actionable intelligence. We offer syndicated reports, custom research, and consulting services tailored to your business needs.

At Precision Market View, we are committed to quality, transparency, and client satisfaction. Every report is rigorously validated to ensure accuracy and relevance. Our global perspective and local expertise help you understand both the big picture and the finer details of your market.

Stay informed with Precision Market View. Subscribe to our newsletter for the latest updates and research highlights, and follow us on social media for real-time insights.

Precision Market View – Clarity for Your Strategic Decisions.

Geographic Coverage of Europe Animal Vaccines Market

Higher Coverage
Lower Coverage
No Coverage

Europe Animal Vaccines Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2020-2034
Base Year 2025
Estimated Year 2026
Forecast Period2026-2034
Historical Period2020-2025
Growth RateCAGR of 9.2% from 2020-2034
Segmentation
    • By Animal Vaccine Type
      • Livestock Vaccines
      • Companion Animal Vaccines
    • By Technology
      • Live Attenuated Vaccines
      • Inactivated Vaccines
      • Toxoid Vaccines
      • Recombinant Vaccines
      • Other Technologies
  • By Geography
    • Germany
    • United Kingdom
    • France
    • Spain
    • Italy
    • Rest of Europe

Table of Contents

  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Objective
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Market Snapshot
  3. 3. Market Dynamics
    • 3.1. Market Drivers
    • 3.2. Market Restrains
    • 3.3. Market Trends
    • 3.4. Market Opportunities
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
      • 4.1.1. Bargaining Power of Suppliers
      • 4.1.2. Bargaining Power of Buyers
      • 4.1.3. Threat of New Entrants
      • 4.1.4. Threat of Substitutes
      • 4.1.5. Competitive Rivalry
    • 4.2. PESTEL analysis
    • 4.3. BCG Analysis
      • 4.3.1. Stars (High Growth, High Market Share)
      • 4.3.2. Cash Cows (Low Growth, High Market Share)
      • 4.3.3. Question Mark (High Growth, Low Market Share)
      • 4.3.4. Dogs (Low Growth, Low Market Share)
    • 4.4. Ansoff Matrix Analysis
    • 4.5. Supply Chain Analysis
    • 4.6. Regulatory Landscape
    • 4.7. Current Market Potential and Opportunity Assessment (TAM–SAM–SOM Framework)
    • 4.8. PMV Analyst Note
  5. 5. Market Analysis, Insights and Forecast 2021-2033
    • 5.1. Market Analysis, Insights and Forecast - by Animal Vaccine Type
      • 5.1.1. Livestock Vaccines
      • 5.1.2. Companion Animal Vaccines
    • 5.2. Market Analysis, Insights and Forecast - by Technology
      • 5.2.1. Live Attenuated Vaccines
      • 5.2.2. Inactivated Vaccines
      • 5.2.3. Toxoid Vaccines
      • 5.2.4. Recombinant Vaccines
      • 5.2.5. Other Technologies
    • 5.3. Market Analysis, Insights and Forecast - by Region
      • 5.3.1. Germany
      • 5.3.2. United Kingdom
      • 5.3.3. France
      • 5.3.4. Spain
      • 5.3.5. Italy
      • 5.3.6. Rest of Europe
  6. 6. Europe Animal Vaccines Market Analysis, Insights and Forecast, 2021-2033
    • 6.1. Market Analysis, Insights and Forecast - by Animal Vaccine Type
      • 6.1.1. Livestock Vaccines
      • 6.1.2. Companion Animal Vaccines
    • 6.2. Market Analysis, Insights and Forecast - by Technology
      • 6.2.1. Live Attenuated Vaccines
      • 6.2.2. Inactivated Vaccines
      • 6.2.3. Toxoid Vaccines
      • 6.2.4. Recombinant Vaccines
      • 6.2.5. Other Technologies
  7. 7. Germany Europe Animal Vaccines Market Analysis, Insights and Forecast, 2020-2032
    • 7.1. Market Analysis, Insights and Forecast - by Animal Vaccine Type
      • 7.1.1. Livestock Vaccines
      • 7.1.2. Companion Animal Vaccines
    • 7.2. Market Analysis, Insights and Forecast - by Technology
      • 7.2.1. Live Attenuated Vaccines
      • 7.2.2. Inactivated Vaccines
      • 7.2.3. Toxoid Vaccines
      • 7.2.4. Recombinant Vaccines
      • 7.2.5. Other Technologies
  8. 8. United Kingdom Europe Animal Vaccines Market Analysis, Insights and Forecast, 2020-2032
    • 8.1. Market Analysis, Insights and Forecast - by Animal Vaccine Type
      • 8.1.1. Livestock Vaccines
      • 8.1.2. Companion Animal Vaccines
    • 8.2. Market Analysis, Insights and Forecast - by Technology
      • 8.2.1. Live Attenuated Vaccines
      • 8.2.2. Inactivated Vaccines
      • 8.2.3. Toxoid Vaccines
      • 8.2.4. Recombinant Vaccines
      • 8.2.5. Other Technologies
  9. 9. France Europe Animal Vaccines Market Analysis, Insights and Forecast, 2020-2032
    • 9.1. Market Analysis, Insights and Forecast - by Animal Vaccine Type
      • 9.1.1. Livestock Vaccines
      • 9.1.2. Companion Animal Vaccines
    • 9.2. Market Analysis, Insights and Forecast - by Technology
      • 9.2.1. Live Attenuated Vaccines
      • 9.2.2. Inactivated Vaccines
      • 9.2.3. Toxoid Vaccines
      • 9.2.4. Recombinant Vaccines
      • 9.2.5. Other Technologies
  10. 10. Spain Europe Animal Vaccines Market Analysis, Insights and Forecast, 2020-2032
    • 10.1. Market Analysis, Insights and Forecast - by Animal Vaccine Type
      • 10.1.1. Livestock Vaccines
      • 10.1.2. Companion Animal Vaccines
    • 10.2. Market Analysis, Insights and Forecast - by Technology
      • 10.2.1. Live Attenuated Vaccines
      • 10.2.2. Inactivated Vaccines
      • 10.2.3. Toxoid Vaccines
      • 10.2.4. Recombinant Vaccines
      • 10.2.5. Other Technologies
  11. 11. Italy Europe Animal Vaccines Market Analysis, Insights and Forecast, 2020-2032
    • 11.1. Market Analysis, Insights and Forecast - by Animal Vaccine Type
      • 11.1.1. Livestock Vaccines
      • 11.1.2. Companion Animal Vaccines
    • 11.2. Market Analysis, Insights and Forecast - by Technology
      • 11.2.1. Live Attenuated Vaccines
      • 11.2.2. Inactivated Vaccines
      • 11.2.3. Toxoid Vaccines
      • 11.2.4. Recombinant Vaccines
      • 11.2.5. Other Technologies
  12. 12. Rest of Europe Europe Animal Vaccines Market Analysis, Insights and Forecast, 2020-2032
    • 12.1. Market Analysis, Insights and Forecast - by Animal Vaccine Type
      • 12.1.1. Livestock Vaccines
      • 12.1.2. Companion Animal Vaccines
    • 12.2. Market Analysis, Insights and Forecast - by Technology
      • 12.2.1. Live Attenuated Vaccines
      • 12.2.2. Inactivated Vaccines
      • 12.2.3. Toxoid Vaccines
      • 12.2.4. Recombinant Vaccines
      • 12.2.5. Other Technologies
  13. 13. Competitive Analysis
      • 13.1. Company Profiles
        • 13.1.1 Boehringer Ingelheim International GmbH
          • 13.1.1.1. Company Overview
          • 13.1.1.2. Products
          • 13.1.1.3. Company Financials
          • 13.1.1.4. SWOT Analysis
        • 13.1.2 Hester Biosciences Ltd
          • 13.1.2.1. Company Overview
          • 13.1.2.2. Products
          • 13.1.2.3. Company Financials
          • 13.1.2.4. SWOT Analysis
        • 13.1.3 Durvet Inc
          • 13.1.3.1. Company Overview
          • 13.1.3.2. Products
          • 13.1.3.3. Company Financials
          • 13.1.3.4. SWOT Analysis
        • 13.1.4 Merck & Co Inc
          • 13.1.4.1. Company Overview
          • 13.1.4.2. Products
          • 13.1.4.3. Company Financials
          • 13.1.4.4. SWOT Analysis
        • 13.1.5 HIPRA
          • 13.1.5.1. Company Overview
          • 13.1.5.2. Products
          • 13.1.5.3. Company Financials
          • 13.1.5.4. SWOT Analysis
        • 13.1.6 Phibro Animal Health Corp
          • 13.1.6.1. Company Overview
          • 13.1.6.2. Products
          • 13.1.6.3. Company Financials
          • 13.1.6.4. SWOT Analysis
        • 13.1.7 Ceva Sante Animale
          • 13.1.7.1. Company Overview
          • 13.1.7.2. Products
          • 13.1.7.3. Company Financials
          • 13.1.7.4. SWOT Analysis
        • 13.1.8 Virbac SA
          • 13.1.8.1. Company Overview
          • 13.1.8.2. Products
          • 13.1.8.3. Company Financials
          • 13.1.8.4. SWOT Analysis
        • 13.1.9 Elanco Animal Health
          • 13.1.9.1. Company Overview
          • 13.1.9.2. Products
          • 13.1.9.3. Company Financials
          • 13.1.9.4. SWOT Analysis
        • 13.1.10 Zoetis Inc
          • 13.1.10.1. Company Overview
          • 13.1.10.2. Products
          • 13.1.10.3. Company Financials
          • 13.1.10.4. SWOT Analysis
      • 13.2. Market Entropy
        • 13.2.1 Company's Key Areas Served
        • 13.2.2 Recent Developments
      • 13.3. Company Market Share Analysis 2025
        • 13.3.1 Top 5 Companies Market Share Analysis
        • 13.3.2 Top 3 Companies Market Share Analysis
    • 13.4. List of Potential Customers
  14. 14. Research Methodology

    List of Figures

    1. Figure 1: Europe Animal Vaccines Market Revenue Breakdown (million, %) by Product 2025 & 2033
    2. Figure 2: Europe Animal Vaccines Market Share (%) by Company 2025

    List of Tables

    1. Table 1: Europe Animal Vaccines Market Revenue million Forecast, by Animal Vaccine Type 2020 & 2033
    2. Table 2: Europe Animal Vaccines Market Volume K Unit Forecast, by Animal Vaccine Type 2020 & 2033
    3. Table 3: Europe Animal Vaccines Market Revenue million Forecast, by Technology 2020 & 2033
    4. Table 4: Europe Animal Vaccines Market Volume K Unit Forecast, by Technology 2020 & 2033
    5. Table 5: Europe Animal Vaccines Market Revenue million Forecast, by Region 2020 & 2033
    6. Table 6: Europe Animal Vaccines Market Volume K Unit Forecast, by Region 2020 & 2033
    7. Table 7: Europe Animal Vaccines Market Revenue million Forecast, by Animal Vaccine Type 2020 & 2033
    8. Table 8: Europe Animal Vaccines Market Volume K Unit Forecast, by Animal Vaccine Type 2020 & 2033
    9. Table 9: Europe Animal Vaccines Market Revenue million Forecast, by Technology 2020 & 2033
    10. Table 10: Europe Animal Vaccines Market Volume K Unit Forecast, by Technology 2020 & 2033
    11. Table 11: Europe Animal Vaccines Market Revenue million Forecast, by Country 2020 & 2033
    12. Table 12: Europe Animal Vaccines Market Volume K Unit Forecast, by Country 2020 & 2033
    13. Table 13: Europe Animal Vaccines Market Revenue million Forecast, by Animal Vaccine Type 2020 & 2033
    14. Table 14: Europe Animal Vaccines Market Volume K Unit Forecast, by Animal Vaccine Type 2020 & 2033
    15. Table 15: Europe Animal Vaccines Market Revenue million Forecast, by Technology 2020 & 2033
    16. Table 16: Europe Animal Vaccines Market Volume K Unit Forecast, by Technology 2020 & 2033
    17. Table 17: Europe Animal Vaccines Market Revenue million Forecast, by Country 2020 & 2033
    18. Table 18: Europe Animal Vaccines Market Volume K Unit Forecast, by Country 2020 & 2033
    19. Table 19: Europe Animal Vaccines Market Revenue million Forecast, by Animal Vaccine Type 2020 & 2033
    20. Table 20: Europe Animal Vaccines Market Volume K Unit Forecast, by Animal Vaccine Type 2020 & 2033
    21. Table 21: Europe Animal Vaccines Market Revenue million Forecast, by Technology 2020 & 2033
    22. Table 22: Europe Animal Vaccines Market Volume K Unit Forecast, by Technology 2020 & 2033
    23. Table 23: Europe Animal Vaccines Market Revenue million Forecast, by Country 2020 & 2033
    24. Table 24: Europe Animal Vaccines Market Volume K Unit Forecast, by Country 2020 & 2033
    25. Table 25: Europe Animal Vaccines Market Revenue million Forecast, by Animal Vaccine Type 2020 & 2033
    26. Table 26: Europe Animal Vaccines Market Volume K Unit Forecast, by Animal Vaccine Type 2020 & 2033
    27. Table 27: Europe Animal Vaccines Market Revenue million Forecast, by Technology 2020 & 2033
    28. Table 28: Europe Animal Vaccines Market Volume K Unit Forecast, by Technology 2020 & 2033
    29. Table 29: Europe Animal Vaccines Market Revenue million Forecast, by Country 2020 & 2033
    30. Table 30: Europe Animal Vaccines Market Volume K Unit Forecast, by Country 2020 & 2033
    31. Table 31: Europe Animal Vaccines Market Revenue million Forecast, by Animal Vaccine Type 2020 & 2033
    32. Table 32: Europe Animal Vaccines Market Volume K Unit Forecast, by Animal Vaccine Type 2020 & 2033
    33. Table 33: Europe Animal Vaccines Market Revenue million Forecast, by Technology 2020 & 2033
    34. Table 34: Europe Animal Vaccines Market Volume K Unit Forecast, by Technology 2020 & 2033
    35. Table 35: Europe Animal Vaccines Market Revenue million Forecast, by Country 2020 & 2033
    36. Table 36: Europe Animal Vaccines Market Volume K Unit Forecast, by Country 2020 & 2033
    37. Table 37: Europe Animal Vaccines Market Revenue million Forecast, by Animal Vaccine Type 2020 & 2033
    38. Table 38: Europe Animal Vaccines Market Volume K Unit Forecast, by Animal Vaccine Type 2020 & 2033
    39. Table 39: Europe Animal Vaccines Market Revenue million Forecast, by Technology 2020 & 2033
    40. Table 40: Europe Animal Vaccines Market Volume K Unit Forecast, by Technology 2020 & 2033
    41. Table 41: Europe Animal Vaccines Market Revenue million Forecast, by Country 2020 & 2033
    42. Table 42: Europe Animal Vaccines Market Volume K Unit Forecast, by Country 2020 & 2033

    Frequently Asked Questions

    1. What is the projected Compound Annual Growth Rate (CAGR) of the Europe Animal Vaccines Market?

    The projected CAGR is approximately 9.2%.

    2. Which companies are prominent players in the Europe Animal Vaccines Market?

    Key companies in the market include Boehringer Ingelheim International GmbH, Hester Biosciences Ltd, Durvet Inc , Merck & Co Inc, HIPRA, Phibro Animal Health Corp, Ceva Sante Animale, Virbac SA, Elanco Animal Health, Zoetis Inc.

    3. What are the main segments of the Europe Animal Vaccines Market?

    The market segments include Animal Vaccine Type, Technology.

    4. Can you provide details about the market size?

    The market size is estimated to be USD 3354 million as of 2022.

    5. What are some drivers contributing to market growth?

    High Burden of Livestock Diseases; Initiatives by Various Government Agencies. Animal Associations. and Leading Players; Increasing Incidences of Zoonotic Diseases.

    6. What are the notable trends driving market growth?

    Live Attenuated Vaccines Segment is Expected to hold the Largest Market Share Over the Forecast Period.

    7. Are there any restraints impacting market growth?

    High Storage Costs for Vaccines; Lack of Veterinarians and Shortage of Skilled Farmers.

    8. Can you provide examples of recent developments in the market?

    January 2022: Boehringer Ingelheim, a German company, and MabGenesis, a private biopharmaceutical firm based in Yokohama, Japan, entered a partnership to identify and develop new monoclonal antibodies for canine therapeutic therapies.

    9. What pricing options are available for accessing the report?

    Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.

    10. Is the market size provided in terms of value or volume?

    The market size is provided in terms of value, measured in million and volume, measured in K Unit.

    11. Are there any specific market keywords associated with the report?

    Yes, the market keyword associated with the report is "Europe Animal Vaccines Market," which aids in identifying and referencing the specific market segment covered.

    12. How do I determine which pricing option suits my needs best?

    The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

    13. Are there any additional resources or data provided in the Europe Animal Vaccines Market report?

    While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

    14. How can I stay updated on further developments or reports in the Europe Animal Vaccines Market?

    To stay informed about further developments, trends, and reports in the Europe Animal Vaccines Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

    Methodology

    Step 1 - Identification of Relevant Samples Size from Population Database

    Step Chart
    Bar Chart
    Method Chart

    Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

    Approach Chart
    Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

    Note*: In applicable scenarios

    Step 3 - Data Sources

    Primary Research

    • Web Analytics
    • Survey Reports
    • Research Institute
    • Latest Research Reports
    • Opinion Leaders

    Secondary Research

    • Annual Reports
    • White Paper
    • Latest Press Release
    • Industry Association
    • Paid Database
    • Investor Presentations
    Analyst Chart

    Step 4 - Data Triangulation

    Involves using different sources of information in order to increase the validity of a study

    These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

    Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

    During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

    Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.